Table 1.
Characteristics of ALS and PLS patients and controls.
| N | Mean | SD | Min | Max | |
|---|---|---|---|---|---|
| Control | |||||
| Age | 28 | 64 | 10.1 | 42 | 78 |
| Disease durarion at baseline (months) | 28 | N/A | N/A | N/A | N/A |
| ALSFRS-R at baseline | 28 | N/A | N/A | N/A | N/A |
| Sex | 28 | 47% Male | |||
| Ethnicity | 28 | 0% Hispanic or Latino; 100% White | |||
| ALS | |||||
| Age | 40 | 62 | 8.807 | 43 | 77 |
| Disease durarion at baseline (months) | 40 | 3.1 | 2.8 | 2 | 10 |
| ALSFRS-R at baseline | 35 | 38.08 | 5.09 | 29 | 46 |
| Sex | 40 | 57.5% Male | |||
| Ethnicity | 40 | 10% Hispanic or Latino; 80% White, 7.5% Black, 2.5% other | |||
| PLS | |||||
| Age | 28 | 59 | 8.81 | 38 | 81 |
| Disease durarion at baseline (months) | 28 | 40 | 25.41 | 1 | 96 |
| ALSFRS-R at baseline | 28 | 30.04 | 5.73 | 16 | 42 |
| Sex | 28 | 54% Male | |||
| Ethnicity | 28 | 0% Hispanic or Latino; 100% White | |||